Peng Rui, Yin Weihua, Wang Fang, Cong Xiangfeng, Lu Bin, Hua Lu, Chen Xi
Center of Clinical Laboratory, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Diagnostic Laboratory Service, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Thromb J. 2023 Mar 14;21(1):28. doi: 10.1186/s12959-023-00471-w.
Risk prediction rules are important to establish appropriate treatment and management strategy for patients with different risk classification of pulmonary embolism (PE). Neutrophils are considered to be related to PE as an essential marker of inflammation. However, few studies have reported the association between neutrophil levels and risk classification of acute PE (APE). The aim of this study was to investigate the role of neutrophil levels upon admission in the assessment of risk classification of APE.
A total of 299 consecutive APE patients and 90 patients without APE confirmed by computed tomographic pulmonary angiography were retrospectively screened. APE patients were stratified into two subgroups according to clinical guidelines: low- (n = 233) and intermediate- and high-risk (n = 60) APE.
The neutrophil levels in intermediate- and high-risk APE patients were significantly higher compared to low-risk APE or non-APE patients (P < 0.001). In multivariable logistic regression analysis, neutrophil levels were significantly and independently associated with intermediate- and high-risk APE (odds ratio = 1.239, 95% confidence interval [CI] 1.055-1.455, P = 0.009). Neutrophil levels were positively correlated with the pulmonary embolism severity index score (r = 0.357, P < 0.001), high sensitive C-reactive protein, D-dimer and pulmonary artery obstruction index (PAOI), in the overall population of APE patients. Receiver-operating characteristic curve analysis revealed that neutrophils had a better diagnostic value for intermediate- and high-risk APE (area under the curve [AUC] = 0.760, 95% CI 0.695-0.826; P < 0.001) compared to PAOI (AUC = 0.719) and D-dimer (AUC = 0.645).
High neutrophil levels upon admission were significantly and independently associated with intermediate- and high-risk APE, which could be regarded as an indicator of inflammation and thrombosis in APE simultaneously. The potent diagnostic role of neutrophil levels and their competitive advantage over PAOI and D-dimer for the assessment of APE risk classification are suggested.
风险预测规则对于为不同风险分级的肺栓塞(PE)患者制定恰当的治疗和管理策略至关重要。中性粒细胞作为炎症的重要标志物,被认为与PE相关。然而,鲜有研究报道中性粒细胞水平与急性PE(APE)风险分级之间的关联。本研究旨在探讨入院时中性粒细胞水平在APE风险分级评估中的作用。
回顾性筛选了299例连续的APE患者以及90例经计算机断层扫描肺动脉造影确诊无APE的患者。根据临床指南,将APE患者分为两个亚组:低风险(n = 233)和中高风险(n = 60)APE。
与低风险APE或非APE患者相比,中高风险APE患者的中性粒细胞水平显著更高(P < 0.001)。在多变量逻辑回归分析中,中性粒细胞水平与中高风险APE显著且独立相关(比值比 = 1.239,95%置信区间[CI] 1.055 - 1.455,P = 0.009)。在APE患者总体人群中,中性粒细胞水平与肺栓塞严重程度指数评分(r = 0.357,P < 0.001)、高敏C反应蛋白、D - 二聚体及肺动脉阻塞指数(PAOI)呈正相关。受试者工作特征曲线分析显示,与PAOI(曲线下面积[AUC] = 0.719)和D - 二聚体(AUC = 0.645)相比,中性粒细胞对中高风险APE具有更好的诊断价值(AUC = 0.760,95% CI 0.695 - 0.826;P < 0.001)。
入院时高中性粒细胞水平与中高风险APE显著且独立相关,这可同时被视为APE中炎症和血栓形成的一个指标。提示中性粒细胞水平在评估APE风险分级方面具有强大的诊断作用及其相对于PAOI和D - 二聚体的竞争优势。